Related Experiment Video
Updated: Jun 20, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Current and Future Perspectives in Psychiatric Drug Discovery
Wendy Alderton1, Eric Karran, Simon Ward
1Zebrafish Business Unit, Summit plc, Oxford, UK. secretariat@smr.org.uk
Drug News & Perspectives
|September 23, 2009
Summary
Experts met to discuss challenges and advances in psychiatric drug discovery for depression, schizophrenia, and addiction. The meeting highlighted current research and future perspectives in developing novel treatments for these complex conditions.
Area of Science:
- Psychiatric Drug Discovery
- Neuroscience
- Pharmacology
Background:
- The Society for Medicines Research convened a meeting on March 12, 2009.
- The meeting focused on current challenges in treating depression, schizophrenia, and addiction.
- Experts from industry and academia participated.
Purpose of the Study:
- To review current challenges in psychiatric disease treatment.
- To present recent advances in novel psychiatric drug development.
- To explore future perspectives in psychiatric drug discovery.
Main Methods:
- A 1-day meeting format.
- Presentations and discussions by experts.
- Review of existing literature and research.
Main Results:
- Identified key challenges in treating depression, schizophrenia, and addiction.
- Highlighted recent advancements in novel therapeutic agents.
- Discussed future directions for psychiatric drug discovery.
Conclusions:
- There is a need for continued research and development in psychiatric drug discovery.
- Collaboration between industry and academia is crucial for progress.
- Novel agents show promise for improving treatment outcomes.
Related Concept Videos
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...